Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check3 days agoChange DetectedRecruitment is now closed, signaling that no further participants are being recruited for the study. The page also includes new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and shows a revision update to v3.6.0.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, signaling a small version update to the underlying template. There is no indication of changes to visible content or functionality.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new publication citation for a 2024 Oncologist article analyzing health-related quality of life in KEYNOTE-590 was added to the Publications section, and an earlier erratum entry related to that article was removed/updated.SummaryDifference0.0%

- Check46 days agoChange DetectedThe locations list adds Taoyuan, Taiwan, 333 (replacing Taoyuan District, Taiwan, 333) to represent a new trial site; a 2026 publication citation about KEYNOTE-590 was added to Publications.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, indicating a general system/version update rather than a change to the study record content.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded the health-related quality-of-life publication for KEYNOTE-590 (Oncologist, 2024) with its erratum and removed the prior reference version (v3.5.0).SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.